The use of prescription medications for the cognitive enhancement of healthy individuals has been a captivating and contentious subject in the media and in the bioethics literature. This chapter provides an overview of the roles the media have played in reporting features of the nonmedical use of prescription medications by healthy individuals for enhancement and the influence the media have exerted on academic discourses. We note the broadening of media coverage from trend reporting to taking on research questions of the prevalence and efficacy of cognitive enhancement. We also reflect on the emergent contribution of messages via social media in online discussions about cognitive enhancement. Messages from traditional and social media are ...
The article explores some of the issues that have arisen in the discourse on pharmaceutical cognitiv...
in pharmacological cognitive enhancement Ahmed Dahir Mohamed1,2,3∗ Neuroethics is an emerging field ...
People vary widely in their acceptance of the use of pharmacological cognitive enhancement (CE). We ...
Over the past few years the use of stimulants such as methylphenidate and modafinil among the studen...
In the debate on the ethics of the non-medical use of pharmaceuticals for cognitive performance enha...
The use of prescription drugs to improve cognitive functioning in normal persons –“neuroenhancement”...
Background: Although some of the most radical hypothesis related to the practical implementations of...
This thesis explores the controversial nature of pharmacological cognitive enhancement (PCE), define...
Sattler S, Wörn J. Public Perceptions of Prescription Drug Use for Cognitive Enhancement in Healthy ...
The use of pharmacological cognitive enhancers (PCEs) in the healthy population is a controversial t...
The use of biomedical technology to enhance the capacities of healthy individuals raises ethics ques...
This is the published manuscript. It is available online from the Wiley in Wiley Interdisciplinary R...
One of the most fascinating issues in the emerging field of neuroethics is pharmaceutical cognitive ...
Background: Donepezil, an acetylcholinesterase inhibitor used in the treatment of Alzheimer\u27s dis...
Abstract Background There is substantial evidence that methylphenidate (MPH; Ritalin), is being used...
The article explores some of the issues that have arisen in the discourse on pharmaceutical cognitiv...
in pharmacological cognitive enhancement Ahmed Dahir Mohamed1,2,3∗ Neuroethics is an emerging field ...
People vary widely in their acceptance of the use of pharmacological cognitive enhancement (CE). We ...
Over the past few years the use of stimulants such as methylphenidate and modafinil among the studen...
In the debate on the ethics of the non-medical use of pharmaceuticals for cognitive performance enha...
The use of prescription drugs to improve cognitive functioning in normal persons –“neuroenhancement”...
Background: Although some of the most radical hypothesis related to the practical implementations of...
This thesis explores the controversial nature of pharmacological cognitive enhancement (PCE), define...
Sattler S, Wörn J. Public Perceptions of Prescription Drug Use for Cognitive Enhancement in Healthy ...
The use of pharmacological cognitive enhancers (PCEs) in the healthy population is a controversial t...
The use of biomedical technology to enhance the capacities of healthy individuals raises ethics ques...
This is the published manuscript. It is available online from the Wiley in Wiley Interdisciplinary R...
One of the most fascinating issues in the emerging field of neuroethics is pharmaceutical cognitive ...
Background: Donepezil, an acetylcholinesterase inhibitor used in the treatment of Alzheimer\u27s dis...
Abstract Background There is substantial evidence that methylphenidate (MPH; Ritalin), is being used...
The article explores some of the issues that have arisen in the discourse on pharmaceutical cognitiv...
in pharmacological cognitive enhancement Ahmed Dahir Mohamed1,2,3∗ Neuroethics is an emerging field ...
People vary widely in their acceptance of the use of pharmacological cognitive enhancement (CE). We ...